SEC Tracker
Get the app
RDNT · XBRL financial data

RadNet financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (RDNT's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue402420*432460461———————
Revenue from contracts with customers402420*432460461477*471498523548*576623
Total operating expenses359396*420425427453*496467495520*600583
Operating income (loss)4324*11353425*(24)312728*(24)39
Interest income———9109*8898*54
Interest expense1617*16261918*17171718*1818
Other income (expense)44*3859*8898*54
Income tax expense (benefit)71*(2)241*(3)1611*(8)6
Net income (loss)18(2)*(3)(3)35*(38)145(1)*(33)8
Earnings per share, basic USD per share0.26(0.03)*(0.04)(0.04)0.040.07*(0.51)0.190.07(0.01)*(0.43)0.10
Earnings per share, diluted USD per share0.25—(0.04)(0.04)0.040.07*(0.51)0.190.07(0.01)*(0.43)0.10
Weighted average shares, basic millions of shares6869*69737376*74747676*7778
Weighted average shares, diluted millions of shares6971*69737581*74767773*7779

Balance sheet

CSV

Fiscal quarters (RDNT's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents338343527742749740717833805767455726
Accounts receivable168164190195199186200200211200209242
Prepaid and other current assets484845393852644850526561
Total current assets5795797961,0051,0161,0191,0161,0941,0781,0327411,036
Property and equipment, net577604619653664695708741781808862880
Right-of-use asset613596622624647640666666675690761759
Goodwill6766796947097127117177528289081,0951,122
Total assets2,6882,6902,9703,2293,2753,2873,3363,5153,6653,7593,8854,226
Accounts payable—123———96———153——
Accrued liabilities—124———153———155——
Current portion of long-term debt161820242325252525252731
Total current liabilities407437428474470480505546575587636698
Long-term debt8448128141,0029969929851,0771,0711,0641,0601,302
Lease liability, non-current614605630632658656678679691707777776
Total liabilities1,8921,8771,8922,1372,1562,1532,2002,3362,3512,4032,5332,832
Accumulated deficit(78)(80)(82)(85)(82)(77)(115)(100)(95)(95)(129)(121)
Total stockholders' equity6196318738818959028989321,0591,0901,0811,096
Total liabilities and equity2,6882,6902,9703,2293,2753,2873,3363,5153,6653,7593,8854,226
Common shares outstanding (cover page) millions of shares686874747474757777787979

Cash flows

CSV

Fiscal quarters (RDNT's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)18(2)*(3)(3)35*(38)145(1)*(33)8
Stock-based compensation4*5*125*5*8*289*9*8*3111*
Depreciation and amortization3233*32343536*35364041*4546
Net cash from operating activities31*89*17116*57*43*41120*53*84*7994*
Net cash from investing activities(47)*(49)*(61)(77)*(46)*(49)*(57)(97)*(76)*(114)*(371)(64)*
Proceeds from issuing common stock(0)*0*2180*0*0*00*0*0*——
Proceeds from long-term debt—year only———year only———year only——
Net cash from financing activities(3)*(35)*228176*(4)*(2)*(8)92*(5)*(7)*(18)240*
Net change in cash(19)*5*184215*7*(9)*(23)116*(28)*(38)*(312)271*

Compare with peers

SIC 8071 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8071 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingRunwayQuarter
RadNet72662394*78.7M— 10-QJun 30, 2026
Caris Life Sciencesnot reported26428*282.6M— 10-QJun 30, 2026
Guardant Health1,053335(58)*134.2M18.2 quarters 10-QJun 30, 2026
GRAIL5645(81)*44.7M0.7 quarters 10-QJun 30, 2026
Lumexa Imaging Holdings7026433*96.1M— 10-QJun 30, 2026
Veracyte30015046*80.4M— 10-QJun 30, 2026
Exact Sciences956878*152*190.9M— 10-KDec 31, 2025
CareDx25013913*52.5M— 10-QSep 30, 2026
Quest Diagnostics7973,097611*110.0M— 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.